In-silico structural analysis of Heterocephalus glaber amyloid beta: an anti-Alzheimer's peptide

被引:1
|
作者
Javanmard, Ali [1 ]
Azimzadeh-Irani, Maryam [1 ]
Tafazzoli, Ghazal [1 ]
Esmaeilzadeh, Ayla [1 ]
Shirinpoor-Kharf, Mohammad [1 ]
Haghayeghi, Seyyed Mohammad Hasan [1 ]
机构
[1] Shahid Beheshti Univ, Fac Life Sci & Biotechnol, Tehran, Iran
关键词
Amyloid Beta; Alzheimer's Disease; Heterocephalus glaber; AlphaFold2; Molecular Docking; NAKED MOLE-RAT; RODENT; DISEASE; MODEL; PATHOLOGY; PRIMATE; HUMANS; DAMAGE;
D O I
10.22099/mbrc.2023.48223.1862
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Heterocephalus glaber, known as the Naked mole-rat, has an extraordinary immunity to Alzheimer's disease. The pathological hallmark of Alzheimer's disease is cerebral accumulations of plaques, consisting of self-aggregated amyloid beta peptides. Homo sapiens and H. glaber amyloid beta peptides are different in only one amino acid. Herein, computational structural analyses were carried out to determine whether plaque development in H. glaber is prevented by the replacement of His13 with Arg13 in the amyloid beta peptide. AlphaFold2 was used to predict the structure of the H. glaber amyloid beta peptide. HADDOCK and Hex were used to self-dock the peptides and dock ions on peptides, respectively. Illustrations were made by PyMol and ChimeraX. Using VMD, we calculated the radius of gyration. The phylogenetic analysis was conducted by Mega. The results showed an accurate structure with two alpha helices separated by a short coil for H. glaber. Self-docking of the two amyloid beta peptides demonstrated a globular conformation in the H. glaber dimer, implying the unlikeliness of amyloid beta peptides' self-aggregation to form fibrillar structures. This conformational state resulted in lower electrostatic energy compared to H. sapiens, contributing to H. glaber's lower tendency for fibril and, ultimately, plaque formation. Phylogenetic analysis confirmed that amyloid precursor protein is highly conserved in each taxon of rodentia and primata. This study provides insight into the connection between the structure of H. glaber amyloid beta and its plaque formation properties, showing that the Arg13 in H. glaber leads to fibril instability, and might prevent senile plaque accumulation.
引用
收藏
页码:29 / 42
页数:14
相关论文
共 50 条
  • [41] Sulphated Fucooligosaccharide from Sargassum Horneri: Structural Analysis and Anti-Alzheimer Activity
    Ling-Jian Zhang
    Hao-Zheng Zhang
    Ya-Wen Liu
    Min Tang
    Yong-Jun Jiang
    Fu-Nan Li
    Li-Ping Guan
    Qing-Hao Jin
    Neurochemical Research, 2024, 49 : 1592 - 1602
  • [42] Comprehensive profiling of traditional herbomineral formulation Manasamitra vatakam in rat brain following oral administration and in-silico screening of the identified compound for anti-Alzheimer's activity
    Nair, Anju C.
    Benny, Sonu
    Aneesh, T. P.
    Sudheesh, M. S.
    Lakshmi, P. K.
    JOURNAL OF ETHNOPHARMACOLOGY, 2025, 338
  • [43] Distinct specificity patterns of anti-beta amyloid peptide antibodies in hemorrhagic and inflammatory cerebral amyloid angiopathy and Alzheimer's disease
    Chantran, Y.
    Capron, J.
    Chaigneau, T.
    Dorothee, G.
    Sarazin, M.
    Alamowitch, S.
    Aucouturier, P.
    INTERNATIONAL JOURNAL OF STROKE, 2015, 10 : 192 - 192
  • [44] Design of beta amyloid anti-aggregation agents for Alzheimer's
    Weaver, DF
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 215 : U923 - U923
  • [45] Modelling of Anti-amyloid-Beta Therapy for Alzheimer's Disease
    Pal, Swadesh
    Melnik, Roderick
    BIOINFORMATICS AND BIOMEDICAL ENGINEERING, IWBBIO 2023, PT I, 2023, 13919 : 431 - 442
  • [46] The Amyloid Beta Peptide: A Chemist's Perspective. Role in Alzheimer's and Fibrillization
    Hamley, I. W.
    CHEMICAL REVIEWS, 2012, 112 (10) : 5147 - 5192
  • [47] Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease
    Reddy, P. Hemachandra
    EXPERIMENTAL NEUROLOGY, 2009, 218 (02) : 286 - 292
  • [48] Disease-Modifying Anti-Alzheimer's Drugs: Inhibitors of Human Cholinesterases Interfering with β-Amyloid Aggregation
    Brogi, Simone
    Butini, Stefania
    Maramai, Samuele
    Colombo, Raffaella
    Verga, Laura
    Lanni, Cristina
    De Lorenzi, Ersilia
    Lamponi, Stefania
    Andreassi, Marco
    Bartolini, Manuela
    Andrisano, Vincenza
    Novellino, Ettore
    Campiani, Giuseppe
    Brindisi, Margherita
    Gemma, Sandra
    CNS NEUROSCIENCE & THERAPEUTICS, 2014, 20 (07) : 624 - 632
  • [49] Collation of fullerenes and carbon nanotubes with genistein for synergistic anti-Alzheimer's activity by amyloid-β deaggregation
    Mehta, Parth
    Shende, Pravin
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 91
  • [50] Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease
    Mark, RJ
    Blanc, EM
    Mattson, MP
    MOLECULAR NEUROBIOLOGY, 1996, 12 (03) : 211 - 224